Bioscience

20 years of TGen: Using genomics for medical benefit

This year marks the 20^th anniversary of both the Arizona’s Bioscience Roadmap and TGen, which through its cutting-edge patient treatment, ground-breaking research, and commercialization, has played a key role in enabling Arizona’s bioscience sector to perform today at historically high levels. 

Dr. Jeffrey Trent, TGen’s president and research director and previously the scientific director of the National Human Genomic Research Institute, talks about his vision to create such an organization—and to do so in his native Arizona. [Read more]

Arizona’s bioscience sector hits record highs, new performance data shows

Arizona’s bioscience sector is performing at historically high levels two decades after the creation of Arizona’s Bioscience Roadmap, according to the latest performance analysis by TEConomy Partners, with record highs in bioscience jobs, wages, venture capital, National Institutes of Health research funding, and university research and development.

The increases are striking: from 73,000 to 133,000 in bioscience jobs, including hospitals; $34 million to $240 million in venture capital; $133 million to $297 million in NIH funding; and $273 million to $623 in academic R&D. [Read more]

Flinn awards $5.5M grant to UArizona College of Medicine-Phoenix

The University of Arizona College of Medicine-Phoenix will receive $5.5 million over five years from the Flinn Foundation to support translational research in cardiovascular diseases, neurosciences, and serious mental illnesses.

The grant, which will help advance research in these areas towards the clinical development of therapeutics, will establish new faculty positions and help develop the Translational Cardiovascular Research Center and a new Department of Translational Neurosciences. Funding will also create an intern program for underrepresented high school students. [Learn more] [Watch video]